Nippon Chemiphar Co., Ltd. (TYO:4539)
Japan
· Delayed Price · Currency is JPY 1,457.00
-20.00 (-1.35%)
May 16, 2025, 2:41 PM JST
Nippon Chemiphar Revenue
Nippon Chemiphar had revenue of 8.68B JPY in the quarter ending December 31, 2024, with 5.45% growth. This brings the company's revenue in the last twelve months to 31.99B, up 4.49% year-over-year. In the fiscal year ending March 31, 2024, Nippon Chemiphar had annual revenue of 30.75B, down -2.57%.
Revenue (ttm)
31.99B
Revenue Growth
+4.49%
P/S Ratio
0.16
Revenue / Employee
36.06M
Employees
887
Market Cap
5.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 30.75B | -811.00M | -2.57% |
| Mar 31, 2023 | 31.56B | -947.00M | -2.91% |
| Mar 31, 2022 | 32.51B | 965.00M | 3.06% |
| Mar 31, 2021 | 31.54B | -215.00M | -0.68% |
| Mar 31, 2020 | 31.76B | -2.43B | -7.10% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |